According to Herbalife's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6.42358. At the end of 2021 the company had a P/E ratio of 9.79.
Year | P/E ratio | Change |
---|---|---|
2021 | 9.79 | -41.92% |
2020 | 16.9 | -20.07% |
2019 | 21.1 | -24.68% |
2018 | 28.0 | 5.04% |
2017 | 26.7 | 73.35% |
2016 | 15.4 | 17.6% |
2015 | 13.1 | 23.84% |
2014 | 10.6 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Nature's Sunshine Products NATR | 56.6 | 780.67% | ๐บ๐ธ USA |
![]() USANA USNA | 18.4 | 187.19% | ๐บ๐ธ USA |
![]() Nu Skin NUS | 16.7 | 160.38% | ๐บ๐ธ USA |
![]() Medifast MED | 6.46 | 0.60% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.